Central macular thickness and foveal avascular zone enlargement may serve as biomarkers for early diabetic retinopathy progression.

LAS VEGAS — Consumer awareness of smart eye wear has nearly doubled in the last 2 years, and four in 10 people now say they would consider a purchase in the next 12 months, according to a report from ...

OCT has transformed retinal practice, enhancing diagnostic accuracy and treatment efficiency while reducing reliance on ...

Apellis Pharmaceuticals recently announced post hoc analysis data of the GALE extension study. This new data is the result of ...

Lilly will also gain exclusive access to MeiraGTx’s gene therapy platform technologies, including novel intravitreal capsids ...

US clinical-stage genetic medicines company MeiraGTx Holdings saw its shares rise 15% to $9.74 pre-market today, as it ...

LONDON and NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage genetic medicines company, today announced a broad strategic ...

MeiraGTx Holdings shares rose sharply in premarket trading Monday after the clinical-stage genetic-medicines said it formed a ophthalmology collaboration potentially worth hundreds of millions of ...

For those seeking cataract surgery in Cedar Rapids, Vance Thompson Vision offers advanced vision correction with a strong ...

In this video from the American Academy of Ophthalmology meeting, Kenneth C. Fan, MD, MBA, highlights outcomes of the STARLIGHT study in Stargardt disease.

Could a virtual reality headset offer a cheaper, easier, and more comfortable method of testing a person's vision, ...

Lilly gains worldwide exclusive rights to MeiraGTx AAV-AIPL1 program for the treatment of Leber congenital amaurosis 4.